Abeona Therapeutics Inc

:ABEO

4.76

-0.20 (-3.94%)

7:32:21 PM EDT: $4.76 0.00 (0.00%)

Market Cap (Intraday)	257.94M
Current PE	N/A
Forward PE	4.14
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$4.42 Million
Adjusted EPS	-$0.35

See more estimates

10-Day MA	$4.99
50-Day MA	$5.13
200-Day MA	$5.61

See more pivots

Abeona Therapeutics Inc Stock, :ABEO

6555 Carnegie Avenue, 4th floor, Cleveland, Ohio 44103

United States of America

Phone: +1.646.813.4701

Number of Employees: 84

http://www.abeonatherapeutics.com

Description

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.